Page 249
References
Electronic Palpation Device Is Adjunct to Manual Breast Exam. Oncology News International. 1999(2).
FDA-cleared breast self-examination pad now available nationwide. Primary Care and Cancer. 1999; 19: 42.
Final Report of the Technology Transfer Workshop on Breast Cancer Detection, Diagnosis, and Treatment. Washington, D.C., USA. May 1-2, 1997. Acad Radiol 1998 Nov;5 Suppl 3: S465-501.
The Cancer Letter. 2000; 15(2).
The Cancer Letter. 2000; 15(3).
Using “Radar” to detect breast cancer. Microwave News. 2000; 8.
[letter]. J Health Care Poor Underserved. 1999; 10: 269-80.
, , , . Utilization of early detection services: a recruitment and screening program for African American womenAnn NY Acad Sci. 1997; 820: 248-70; discussion 271.
, , . Advances in optical imaging of biomedical media.[see comments]. Nature. 2000; 403: 503-11.
, , , et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingBreast Cancer Res Treat. 1999; 55: 243-58.
, , , , . A study on the cost effectiveness of sestamibi scintimammography for screening women with dense breasts for breast cancer.Philadelphia: Lippincott Williams & Wilkins; 2000: 355-366. Harris JR.
, ; Biological features of human premalignant breast disease. In: Diseases of the Breast.2000.
. Cancer Facts and Figures;Adopted on February 20, 1996. J Clin Oncol. 1996; 14: 1730-6; discussion 1737-40.
. Statement on genetic testing for cancer susceptibility,Breast Cancer Res Treat. 1996; 39: 119-35.
, , . Transgenic mouse models of breast cancer.Biomedical Thermology. 1995; 15: 135-9.
. Mechanism of hyperthermia of the cancerous breast.Page 250
Infrared Technology and Applications XXV: April 5, 1999-April 9, 1999; Orlando, FL. Part of the SPIE Conference on Infared Technology and Applications XXV.
, , , . Clinical Applications of DAT using a QWIP FPA camera.Thermology International. 1999; 127-33.
, , . Objective identification of cancerous breasts by dynamic area telethermometry (DAT).[news]. J Natl Cancer Inst. 1994; 86: 1580-2.
. Issues raised on availability of breast cancer materials for researchBr J Cancer. 1997; 76: 1546-9.
, , , et al. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy.Phys Med Biol. 1998a; 43: 2845-52.
, , , et al. Low-dose phase contrast x-ray medical imaging.Radiology. 1998b; 208: 709-15.
, , , et al. Mammography of a phantom and breast tissue with synchrotron radiation and a linear-array silicon detector.Radiology. 2000; 215: 286-93.
, , , et al. Mammography with synchrotron radiation: phase-detection techniques.[editorial]. J Gen Intern Med. 1995; 10: 295-7.
. To screen or not to screen: What is the question?1999.
The Clinical Assessment of Electronic Palpation Technology: A New Approach for the Early Detection and Monitoring of Breast Lesions.Acad Radiol. 1998; 5 Suppl 2: S389-91.
. Technology assessment and reimbursement for future new imaging technologies.Ann Intern Med. 1994; 120: 326-34.
. The Canadian National Breast Screening Study: a perspective on criticisms.Cancer. 1990; 65: 1663-9.
, . Women's attitudes to screening after participation in the National Breast Screening Study. A questionnaire survey.[see comments]. JAMA. 1990; 264: 235-40.
, . The case for reassessment of health care technology. Once is not enoughJAMA. 1999; 282: 1270-80.
, , . Does this patient have breast cancer? The screening clinical breast examination: should it be done? How?Adv Cancer Res. 1998; 72: 141-96.
, , , , . Alterations in DNA methylation: a fundamental aspect of neoplasia.Arch Intern Med. 1996; 156: 209-13.
, , . Variability in the interpretation of screening mammograms by US radiologists. Findings from a national sample.Acad Radiol. 1996; 3: 891-7.
, , . Effect of human variability on independent double reading in screening mammography.Cancer Res. 1993; 53: 2644-54.
, . Culture of normal and malignant primary human mammary epithelial cells in a physiological manner simulates in vivo growth patterns and allows discrimination of cell type.[see comments]. AJR Am J Roentgenol. 1999; 173: 1161-7.
. The missed breast cancer: perceptions and realities[see comments]. J Natl Cancer Inst. 1998; 90: 1431-9.
. Benefits and risks of screening mammography for women in their forties: a statistical appraisalHum Mutat. 1998; 12: 226-37.
, , , . Mutations of the human E-cadherin (CDH1) gene.Mor Mortal Wkly Rep CDC Surveill Summ. 1999; 48: 1-22.
, , . Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997)—Behavioral Risk Factor Surveillance System.BMJ. 2000; 321: 665-669.
, , , , . Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality.Page 251
1997. Volume 12.
. Scintimammography;Endoscopy. 1996; 28: 372-80.
. Tissue spectroscopy for gastrointestinal diseases.Acta Radiol. 1997; 38: 489-96.
, , , . Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions.Acta Oncol. 1992; 31: 151-5.
. Role of genetic factors in breast cancer susceptibility.Am J Roentgenol. 1990; 155: 43-7.
, , , , . Optical spectroscopy (INVOS) is unreliable in detecting breast cancer.Era of Hope Department of Defense Breast Cancer Program Meeting: June, 2000.
, , , , . Optical biopsy for the diagnosis of breast tumors.Am J Manag Care. 1998; 4 Spec No:SP139-50.
, , , . Role of technology assessment in health benefits coverage for medical devices.[see comments] [published erratum appears in N Engl J Med 2000 Jul 27;343(4): 308]. N Engl J Med. 2000; 342: 525-33.
, , , et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer1998.
. Charting The Course: Priorities For Breast Cancer Research: Breast Cancer Progress Review Group;N Engl J Med. 1996; 335: 1963-7.
, , . Relation between negligent adverse events and the outcomes of medical-malpractice litigationDiagn Imaging (San Franc). 2000; 22.
. Small change for big medicine: The crisis in breast imaging services.Non-Invasive System for Breast Cancer Detection5704355. 1998 Jan 6.
, inventor;Am J Hum Genet. 2000; 66: 494-500.
, , , et al. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.JAMA. 1999; 281: 347-53.
, . Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing.Breast Cancer Res Treat. 1993; 25: 113-8.
, . Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature.AJR Am J Roentgenol. 1995; 165: 1373-7.
, , , . Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures.Radiology. 1995; 195: 239-44.
, , , et al. Mammography with synchrotron radiation.Arch Pathol Lab Med. 1998; 122: 871-4.
, . Specimen banks for cancer prognostic factor research.Cancer Genetics Studies Consortium [see comments]. JAMA. 1997; 277: 997-1003.
, , , et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2.Ann Intern Med. 1999; 131: 1-6.
, , , . Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization.Radiographics. 1998; 18: 1587-98.
, , , et al. Analysis of mammographic density and breast cancer risk from digitized mammograms.The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer, [see comments]. . 1998; 158 Suppl 3: S3-8.
. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected.Page 252
Ultrasound Med Biol. 1998; 24: 945-52.
, , , et al. 3-D color Doppler image quantification of breast masses.MMWR Morb Weekly Report. 1998; 47: 853-6.
. Use of cervical and breast cancer screening among women with and without functional limitations—United States, 1994-1995.Radiology. 1999; 212: 817-27.
, , , et al. Improvement of radiologists' characterization of mammographic masses by using computer-aided diagnosis: an ROC study.Ann N Y Acad Sci. 1998; 838: 29-45.
. Near-infrared images using continuous, phase-modulated, and pulsed light with quantitation of blood and blood oxygenation.3d, . Specific value of computed tomographic breast scanner (CT/M) in diagnosis of breast diseases. Radiology. 1979; 132: 647-52.
, , ,Cancer. 1980; 46: 939-46.
, , , et al. Computed tomography in detection and diagnosis of breast cancer.Radiology. 1977; 124: 827-9.
, , , et al. Computed tomography of the breast. A preliminary report.Indian J Biochem Biophys. 1984; 21: 76-9.
, , , . Dielectric properties of normal & malignant human breast tissues at radiowave & microwave frequencies.Cancer Res. 1998; 58: 1376-9.
, , , , . The role of ataxia-telangiectasia heterozygotes in familial breast cancer.Cancer Treat Rev. 2000; 26: 91-102.
, , . Tumour marker measurements in the diagnosis and monitoring of breast cancer.J Natl Cancer Inst. 2000; 92: 1657-66.
, , , et al. Predicting the cumulative risk of false-positive mammograms.Epithelial Cell Biol. 1994; 3: 38-46.
, , , . An immunomagnetic separation method using superparamagnetic (MACS) beads for large-scale purification of human mammary luminal and myoepithelial cells.Scientific American. 1994; 271: 46-53.
SQUIDS.Cancer Treat Rev. 2000; 26: 291-302.
, , . Breast cancer risk following irradiation for Hodgkin's disease.1999.
High Through Put Expression Profiling With Atlas;Ann Oncol. 1995; 6 Suppl 2: 11-21.
. The natural history of operable breast cancer after primary treatment.J Cancer Educ. 1991; 6: 83-92.
. Practice and effectiveness of breast self examination: a selective review of the literature (1977-1989).N Engl J Med. 2000; 342: 1887-92.
, , . Randomized, controlled trials, observational studies, and the hierarchy of research design.Nat Genet. 1997; 17: 423-30.
, , , et al. Tumorigenesis and a DNA repair defect in mice with a truncating BRCA2 mutation.Am J Hum Genet. 1997; 61: 259-66.
, . The regulation of splice-site selection, and its role in human disease.Science. 1999; 286: 1162-6.
, , , . Requirement of ATM-dependent phosphorylation of brcal in the DNA damage response to double-strand breaks.Nat Genet. 2000; 24: 132-8.
, , , et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.Ann Oncol. 1994; 5: 305-11.
, . Clinical prognostic significance of tumour angiogenesis.Surg Gynecol Obstet. 1929; 48: 721-9.
. Transillumination as an aid in the diagnosis of breast lesions.Page 253
Lancet. 1998; 352: 359-63.
, , , et al. Electropotential measurements as a new diagnostic modality for breast cancer.J Natl Cancer Inst. 2000; 92: 452-6.
, , , et al. Participation in the cooperative family registry for breast cancer studies: issues of informed consent.Am J Pathol. 1996; 148: 313-9.
, , , , . MCF10AT: a model for the evolution of cancer from proliferative breast disease.Radiology. 1996; 201: 433-7.
, , , . Mobile mammography: results of a national survey.Q J Nucl Med. 1999; 43: 125-31.
, , . Clinical imaging of multidrug resistance in cancer.et al., Genetic Information and the Workplace: (January 20, 1998).
Ann Intern Med. 1990; 113: 147-54.
, . A clinician's guide to cost-effectiveness analysis.Breast Cancer. 1997; 4: 228-233.
, , , . Computer-Aided Diagnosis of Breast Cancer on Mammograms.Am J Roentgenol. 1995; 165: 281-4.
, , , . Selective use of image-guided large-core needle biopsy of the breast: accuracy and cost-effectiveness.Br J Cancer. 1997; 76: 377-81.
, , , , . Sensitivity, specificity and predictive values of breast imaging in the detection of cancer.Cancer Epidemiol Biomarkers Prev. 1999; 8: 843-54.
, , , , , . A systematic review of genetic polymorphisms and breast cancer risk.1996.
. Cost and Benefit Analysis of Regulation Under the Mammograpgy Quality Standards Act of 1992 Preliminary Report;The Breast Cancer Linkage Consortium. Am J Hum Genet. 1993; 52: 678-701.
, , , . Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families.Del Med J. 1999; 71: 377-82.
, . Current imaging modalities for the diagnosis of breast cancer.J Clin Oncol. 2000; 18: 1980-95.
, , , . Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer.Proc Natl Acad Sci U S A. 1998; 95: 14863-8.
, , , . Cluster analysis and display of genomewide expression patterns.JAMA. 1999; 282: 1865-9.
. Ten lessons for evidence-based technology assessment.Diagn Imaging (San Franc). 2000; 22(4): 31-3, 69.
. Shortage of qualified breast imagers could lead to crisis.N Engl J Med. 1998a; 338: 1089-96.
, , , , , . Ten-year risk of false positive screening mammograms and clinical breast examinations.J Womens Health. 1998b; 7: 443-9.
, , . Does diagnostic accuracy in mammography depend on radiologists' experience?N Engl J Med. 1994; 331: 1493-9.
, , , , . Variability in radiologists' interpretations of mammograms.Science. 1996; 274: 998-1001.
, , , et al. Laser capture microdissection.Cancer Res. 1978; 38: 4327-39.
, . Human breast carcinoma cells in continuous culture: a review.J Natl Cancer Inst Monogr. 1997: 151-6.
, . Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma.Page 254
JAMA. 1996; 275: 913-8.
, , , , . Incidence of and treatment for ductal carcinoma in situ of the breast.In press.
, , , et al. Prevention Clinical Trial Models Utilizing Breast Intraepitheial Neoplasia as an Endpoint.Surg Oncol Clin N Am. 1997; 6: 285-99.
, . The role of stereotactic biopsy in abnormal mammograms.Seminars In Breast Disease. 1999; 2: 74-88.
, , , . Magnetic Resonance Imaging of Breast Tumors.Radiol Clin North Am. 2000; 38: 825-42.
, . An introduction to economic issues in breast imaging.Eur J Radiol. 1997; 24: 33-8.
, , , et al. Electropotential evaluation as a new technique for diagnosing breast lesions.IEEE Microwave and Guided Wave Letters. 1999; 9: 470-2.
, . Microwave System for Breast Tumor Detection.1999; 64(80): 22619-25.
. Medicare Program: Procedures for Making National Coverage Decisions.2000; 65(95): 31124-29.
. Medicare Program: Criteria for Making Coverage Decisions.2000a.
. SBI News, President's Message: Behind the Scenes of an SBI Epic Production;1999a; 2: 3-16.
. Principles and practice of breast imaging, Seminars in breast disease.Radiol Clin North Am. 2000b; 38: 843-52.
. Economic challenges in breast imaging. A survivor's guide to success.1999b.
. President's Message: SBI Residency Training Curriculum;Semin Nucl Med. 1999c; 29: 3-15.
. Role and evaluation of mammography and other imaging methods for breast cancer detection, diagnosis, and staging.J Natl Cancer Inst Monogr. 1997: 119-24.
, . Radiation risk from screening mammography of women aged 40-49 years.Radiology. 1977; 122: 123-7.
, , , et al. Thermography, mammography, and clinical examination in breast cancer screening. Review of 16,000 studies.J Natl Cancer Inst. 1998a; 90: 1371-88.
, , , et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.J Clin Oncol. 1998b; 16: 441-52.
, , , et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.Nat Genet. 1997; 15: 307-10.
, , , et al. Heterozygous ATM mutations do not contribute to early onset of breast cancer.Arch Pathol Lab Med. 2000; 124: 966-78.
, , , et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.3rd Ed. Baltimore, MD: Williams & Wilkins; 1996.
., , . Clinical Epidemiology - the Essentials.Science. 2000; 287: 2017-9.
, , , et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids.Oncogene. 1999; 18: 7334-42.
, , , , , . Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2.Lancet. 1994; 343: 692-5.
, , , , . Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.[see comments]. IEEE Eng Med Biol Mag 1998; 17: 10-4.
. Thermographic detection of breast cancerPage 255
Med Care. 1991; 29: 1065-82.
, . The effect of physician-patient communication on mammography utilization by different ethnic groups.Health Aff (Millwood). 1999; 18: 11-21.
. Health care for the elderly: how much? Who will pay for it?Jpn J Cancer Res. 1996; 87: 1092-6.
, , , et al. Prospective evaluation of skin surface electro-potentials in Japanese patients with suspicious breast lesions.Science. 1999; 285: 1359-61.
, , , et al. Privacy in genetics research.[see comments] [published erratum appears in J Clin Oncol 1999 Feb; 17(2): 740]. J Clin Oncol. 1998; 16: 3105-14.
, . Risk-based recommendations for mammographic screening for women in their fortiesCambridge; 1999.
. The Sources of Industrial Leadership, Edited by David Mowery and Richard Nelson.Eur J Cancer. 2000; 36: 1661-70.
, . Clinical imaging of cancer metastasis.New York: Oxford University Press; 1996.
, , , . Cost-Effectiveness in Health and Medicine.Radiographics. 1990; 10: 1111-31.
, , . Highlights from the history of mammography.Semin Nucl Med. 1999; 29: 41-8.
, . Breast cancer imaging with radiolabeled antibodies.Kramer, BS; Gohagan, JK; Prorok, PC Cancer Screening: Theory and Practice. New York: M. Dekker; 1999: 13-26.
. Heroic Myths and Probability: Confronting the Limits of Screening. From:AJR Am J Roentgenol. 2000; 174: 1211-3.
, , , . Diagnostic radiology residents in the classes of 1999 and 2000: fellowship and employment.Am J Manag Care . 1998; 4 Spec No:SP200-14; quiz SP215-6.
. Healthcare technology assessment: methods, framework, and role in policy making.Lancet. 2000; 355: 129-34.
, . Is screening for breast cancer with mammography justifiable?Prev Med. 1992; 21: 766-80.
, , , . The importance of physician encouragement in breast cancer screening of older women.New Scientist. 1999.
. Closing in on cancer.Br J Cancer. 1990; 62: 1018-22.
, , . Quality of life following a false positive mammogram.J Magn Reson Imaging. 1998; 8: 1191-7.
, , , et al. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil.Anticancer Res. 1999; 19: 1737-46.
, , , , . Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy.Arch Pathol Lab Med. 1998; 122: 1065-76.
, , , , , . Providing human tissues for research: how to establish a program.[see comments]. Nat Genet. 1996; 14: 441-7.
, , , , . Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysisJ Med Genet. 1999; 36: 730-6.
, . Mutational analysis using oligonucleotide microarrays.IEEE Trans Biomed Eng 1999 Mar; 46(3): 364]. IEEE Trans Biomed Eng. 1998; 45: 1470-9.
, , . Two-dimensional FDTD analysis of a pulsed microwave confocal system for breast cancer detection: fixed-focus and antenna-array sensors [published erratum appears inPage 256
BMJ. 1997; 314: 864-7.
, , , . Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study.Washington Fax. 2000.
. Bill to create bioimaging, bioengineering institute at NIH clears House. Advocates hope for pre-recess vote on Lott-sponsored Senate companion bill.Proc Natl Acad Sci U S A. 1982; 79: 4672-6.
, , . Lumen formation by epithelial cell lines in response to collagen overlay: a morphogenetic model in culture.N Engl J Med. 1991; 325: 599-605.
, , . Thyroid diseases after treatment of Hodgkin's disease.Lancet. 1998; 351: 1393-6.
, , , et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.MAMM. 2000 ;3.
. Services denied: why women with disabilities aren't screened for cancer.Kramer BS, Gohagan JK, Prorok PC, eds. Cancer Screening: Theory and Practice. New York: M. Dekker; 1999: 595-609.
. Genetic inheritance of cancer risk: applications to cancer screening. From:Kramer BS, Gohagan JK, Prorok PC, eds. Cancer Screening: Theory and Practice. New York: M. Dekker; 1999: 55-75.
. Decision-making about screening: individual and policy levels. From:Proceedings of the Annual Meeting of the American Association for Cancer Research: 2000.
, , , et al. Bilateral Prophylactic Mastectomy (PM) in BRCA1/ 2 Mutation Carriers.1993 ARRS President's Award [see comments]. AJR Am J Roentgenol. 1993; 161: 1167-72.
, , . Previous mammograms in patients with impalpable breast carcinoma: retrospective vs blinded interpretation.1998. Edited by: Clark C. Havighurst, James F. Blumstein and Troyen A. Brennan. 2nd Edition. New York: Foundation Press, 1998.
. Health care law and policy: readings, notes and questions.[see comments]. J Natl Cancer Inst. 1996; 88: 1456-66.
, , , et al. Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markersBreast Cancer Res Treat. 1998; 52: 305-19.
, , . Assessing the clinical impact of prognostic factors: when is “statistically significant” clinically useful?[letter; comment]. Cancer. 1997; 79: 186-8.
, . Thermography. Its relation to pathologic characteristics, vascularity, proliferation rate, and survival of patients with invasive ductal carcinoma of the breast1996. 96-4159.
. Investigational Device Exemptions Manual;1995.
. Interagency Agreement Between the Food and Drug Administration and the Health Care Financing Administration Regarding Medicare Coverage of Certain Investigational Medical Devices (IDE Memorandum D95-2).Br J Radiol. 1997; 70 Spec No:S206-14.
, . Diagnostic imaging with light.[see comments]. Cancer. 1998; 82: 2221-6.
, , . The benefits of mammography are not limited to women of ages older than 50 yearsEur J Cancer. 2000; 36: 1631-9.
, . Individual characterisation of the metastatic capacity of human breast carcinoma.[see comments]. Lancet. 1999; 354: 99-105.
, , , et al. Early Lung Cancer Action Project: overall design and findings from baseline screeningPage 257
Breast Cancer Res Treat. 1999; 58: 183-6.
, , , , , . Research potential of a unique xenograft model of human proliferative breast disease.Cancer. 1999; 85: 427-31.
, , , et al. Predictors of local recurrence following excision alone for ductal carcinoma in situ.Acad Radiol. 1996; 3: 351-60.
, , . Estimating the cost-effectiveness of stereotaxic biopsy for nonpalpable breast abnormalities: a decision analysis model.1998.
. Uninsured in America: A Chart Book. The Kasier Commission on Medicaid and the Uninsured.Acad Radiol. 2000; 7: 905-7.
, . Molecular imaging in cancer: future directions and goals of the National Cancer Institute.[editorial]. Science. 1999; 286: 409.
. Are genetic tests adequately regulated?Acad Radiol. 2000; 7: 684-92.
, , , et al. Study design in the evaluation of breast cancer imaging technologies.Radiology. 1999; 213: 39-49.
, , , , , . Cost-effectiveness of MR imaging and core-needle biopsy in the preoperative work-up of suspicious breast lesions.Acad Radiol. 1999; 6: 387-97.
, , , . Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis.Am J Managed Care. 2000; 6: 766-80.
, , . Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.Radiol Manage. 1998; 20: 31-9.
. The negative impact of MQSA (Mammography Quality Standards Act) on rural mammography programs.M Hewitt and JV Simone, editors. Washington, D.C.: National Academy Press; 1999.
. Ensuring Quality Cancer Care.Aaron HJ, Gelband H., editors. Washington, D.C.: National Academy Press; 2000.
. Extending Medicare Reimbursement in Clinical Trials.Washington, D.C.: National Academy Press; 1996.
. Mathematics and Physics of Emerging Biomedical Imaging.Washington, D.C.: National Academy Press; 1997.
. A Review of the Department of Defense's Program for Breast Cancer Research.Washington, D.C.: National Academy Press; 1993.
. Strategies for Managing the Breast Cancer Research Program: A Report to the U.S. Army Medical Research and Development Command.Genes Chromosomes Cancer. 1999; 26: 286-94.
, , , et al. Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer.Am J Surg. 1999; 177: 518-24.
. Breast cancer screening.Int J Radiat Oncol Biol Phys. 1980; 6: 681-7.
, , , . Microwave power absorption differences between normal and malignant tissue.Med Phys. 1994; 21: 547-50.
, , , . The measured electrical properties of normal and malignant human tissues from 50 to 900 MHz.IEEE Trans Med Imaging . 1998; 17: 1019-27.
. A reappraisal of the use of infrared thermal image analysis in medicine.Medical Devices, Obtaining FDA Market Clearence. 1995. PARAXEL International Corporation, Waltham, MA.
The Framework for Regulation of Medical Devices.JAMA. 1994; 272: 530-4.
, . Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States.Page 258
J Natl Cancer Inst Monogr. 1997: 79-86.
. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit.JAMA. 1993; 270: 2444-50.
, , , , , . Positive predictive value of screening mammography by age and family history of breast cancer.JAMA. 1996; 276: 39-43.
, , , , . Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation.JAMA. 1995; 273: 149-54.
, , , , . Efficacy of screening mammography. A meta-analysis.JAMA. 1999; 282: 2156-63.
, , , , . Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.Naked to the Bone: Medical Imaging in the Twentieth Century. New Brunswick, NJ: Rutgers University Press; 1997.
.J Am Coll Surg. 1994; 178: 491-7.
, , , et al. Prone scintimammography in patients with suspicion of carcinoma of the breast.Breast Cancer Res Treat. 1999; 53: 177-83.
, , , , , . The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer.New Scientist. 1999.
. More gain, less pain.J Magn Reson Imaging. 1999; 10: 260-6.
, , , et al. Pathophysiologic basis of contrast enhancement in breast tumors.Breast Cancer Working Group. J Womens Health. 1998; 7: 531-45.
, , , , . Genetic testing for BRCA1 and BRCA2: recommendations of the Stanford Program in Genomics, Ethics, and Society.ADVANCE for Administrators in Radiology and Radiation Oncology. 2000.
. Multidisciplinary breast cancer survival, part I and II.Radiology. 1998; 207: 191-9.
, , . Occult cancer in women with dense breasts: detection with screening US—diagnostic yield and tumor characteristics.Nat Med. 1998; 4: 844-7.
, , , et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens.Am J Roentgenol. 1992; 158: 521-6.
. The positive predictive value of mammography.Radiology. 1996; 200: 357-60.
, , , et al. Positive predictive value of breast biopsy performed as a result of mammography: there is no abrupt change at age 50 years.Med Phys. 1996; 23: 187-96.
, , , et al. Imaging characteristics of x-ray capillary optics in digital mammography.inventor; Photoacoustic Breast Scanner 5713356. 1998 Feb 3.
,SPIE. 1999; 3659: 426-30.
, , , . Application of thermoacoustic computed tomography to breast imaging.Radiology. 1999; 211: 275-8.
, , , , , . Thermoacoustic CT with radio waves: a medical imaging paradigm.Radiology. 2000; 215: 267-79.
, , , et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.J Magn Reson Imaging. 1999; 10: 159-64.
, , , et al. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy.Page 259
Oncogene. 1999; 18: 7644-55.
, . Regulation of p53 in response to DNA damage.Science. 1980; 209: 1197-203.
. Estimating cancer risks from low doses of ionizing radiation.Cancer Detect Prev. 1996; 20: 332-41.
, , . Trends in mammography use and their relation to physician and other factors.Larsen LE, Jacobi JH, Eds. Medical Applications of Microwave Imaging. Piscataway, NJ: IEEE Press; 1986.
J Natl Cancer Inst. 1998; 90: 1792-800.
, , , et al. Serendipity in diagnostic imaging: magnetic resonance imaging of the breast.Can. Med. Assoc. J. 1956; 75: 309-10.
. Implications of surface temperatures in the diagnosis of breast cancer.J Natl Cancer Inst. 1996; 88: 643-9.
, , , . Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography.Health Psychol. 1991; 10: 259-67.
, , , , , . Psychological side effects of breast cancer screening.2001. (see http://www4.nationalacademies.org/IOM/IOMHome.nsf/Pages/Breast+Cancer+Detection)
To See Today With the Eyes of Tomorrow: A History of Screening Mammography.Diagn Imaging (San Franc). 1999; 21: 40-5.
. Full-field digital mammography. A candid assessment.Radiology 2001; 218: 873-80.
, , , , , , , , . Comparison of full-field digital mammography with screen-film mammography for cancer detection: results of 4945 paired examinations.2000 Annual Meeting of the Radiological Society of North America.
, , , , . Clinical Evaluation of Full-Field Digital Mammography in a Screening Population.Nature. 2000; 406: 210-5.
, , , et al. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response.Nat Genet. 1997; 16: 64-7.
, , , et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.N Engl J Med. 2000; 343: 78-85.
, , , et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland.BMJ. 1996; 312: 273-6.
, , , . Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial.JAMA 2000 Apr 19;283(15): 1963]. JAMA. 1999; 282: 1061-6.
, , , et al. Empirical evidence of design-related bias in studies of diagnostic tests [published erratum appears in2000; 2: 13-14.
, . Beyond the genome to tissue proteomics. Breast Cancer Research.Nat Biotechnol. 2000; 18: 321-5.
, , , et al. In vivo visualization of gene expression using magnetic resonance imaging.Lancet. 1996; 348: 997-9.
, . Breast-duct endoscopy to study stages of cancerous breast disease.Proceedings, Era of Hope Dept. of Defense Breast Cancer Research Program Meeting. 2000 June.
, , , et al. Development of Intraductal Techniques for Breast Cancer Prevention, Diagnosis and Treatment.Reading, PA: Addison-Wesley; 1995.
, . Dr. Susan Love's Breast Book.Page 260
Cancer. 1999; 85: 1114-8.
, , , . Psychologic distress in women with abnormal findings in mass mammography screening.Cancer Res. 1998; 58: 4721-7.
, , , , , . Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia.Science. 2000; 289: 1760-3.
, . Printing proteins as microarrays for high-throughput function determination.Radiology. 1997; 204: 661-6.
, , , et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.Radiology. 1999; 213: 866-70.
, , , . Near-infrared optical imaging of protease activity for tumor detection.Health Serv Res. 1999; 34: 229-39.
, , . Low income, race, and the use of mammography.Science. 1990; 250: 1233-8.
, , , et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.Prev Med. 1999; 28: 418-25.
, , , et al. Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care.Cancer Epidemiol Biomarkers Prev. 1999; 8: 759-67.
, . Effectiveness of interventions designed to increase mammography use: a meta-analysis of provider-targeted strategies.J Health Care Poor Underserved. 1995; 6: 342-51.
, , , , . Impact of access and social context on breast cancer stage at diagnosis.J Natl Cancer Inst. 2000; 92: 1081-7.
, , , et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.Annu Rev Public Health. 1995; 16: 283-306.
, , . PSA screening: a public health dilemma.Ann Clin Lab Sci. 1997; 27: 47-56.
, , . Current applications of molecular cytogenetic technologies.[news]. Science. 1993; 259: 616-7.
. The politics of breast cancerInt J Cancer. 1997; 74: 443-5.
, , , . Soluble CD44 splice variants in metastasizing human breast cancer.Wall Street Journal. 2000.
. Screening Crunch—As more women seek mammograms, many have to wait months.Lancet. 1992; 340: 1053-8.
, . Significance of CD44 gene products for cancer diagnosis and disease evaluation.Prev Med. 1999; 28: 386-94.
, , , . Compliance with mammography guidelines: physician recommendation and patient adherence.IEEE Trans Med Imaging. 1999; 18: 508-18.
, , , , . Nonactive antenna compensation for fixed-array microwave imaging: Part II—Imaging results.Bethesda, MD: Medical Technology Leadership Forum; 1999.
. MTLF Summit: Conditional Coverage of Investigational Technologies.Semin Ultrasound CT MR. 2000; 21: 297-307.
, , . Use of Doppler ultrasound in the evaluation of breast carcinoma.Magn Reson Imaging Clin N Am. 1994; 2: 691-703.
. MR spectroscopy of the breast.Seminars in Breast Disease. 1999; 2: 89-96.
. Future directions in breast ultrasonography.CA Cancer J Clin. 1999; 49: 138-44.
. Global breast cancer mortality statistics.Page 261
Radiology. 1997; 204: 575-6.
, , , et al. Stereotactic breast biopsy of clustered microcalcifications with a directional, vacuum-assisted device.Science. 1994; 266: 66-71.
, , , et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.2000.
. Better Information, Better Outcomes? The Use of Health Technology Assessment and Clinical Effectiveness Data in the United Kingdom and the United States;Can Med Assoc J 1993 Mar 1;148(5): 718]. CMAJ. 1992; 147: 1477-88.
, , , . Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years [published erratum appears inJ Natl Cancer Inst. 2000; 92: 1490-1499.
, , , . Canadian National Breast Screening Study-2: 13-Year Results of a Randomized Trial in Women Aged 50-59 Years.BMJ. 2000; 321: 1071-1073.
, , , . Is clinical breast examination an acceptable alternative to mammographic screening?Epithelial Cell Biol. 1995; 4: 52-62.
, , , , . Epidermal growth factor receptor expression on human breast luminal and basal cells in vitro.Breast Cancer Res Treat. 1995; 36: 1-9.
. When can stereotactic core biopsy replace excisional biopsy?—A clinical perspective.J Reprod Med. 1985; 30: 451-9.
. Thermography as a risk indicator of breast cancer. Results of a study and a review of the recent literature.National Cancer Institute; 1989. Grant Number CA37970.
, , , . Breast Cancer Diagnosis by Lightscan (Revised) Final Report:Kramer BS, Gohagan JK, Prorok PC, eds. Cancer Screening: Theory and Practice. New York: M. Dekker; 1999: 143-170.
. Breast cancer. In:Department of Defense Breast Cancer Research Program Meeting: June, 2000; Atlanta, GA.
, , , et al. Magnetic Resonance Spectroscopy Determines Pathology, Vascularisation and Node Status. Era of Hope.Lasers Surg Med. 1995; 17: 350-7.
, , , , , . Spectroscopic diagnosis of bladder cancer with elastic light scattering.Am J Prev Med. 1998; 14: 143-53.
, , . Estimating the accuracy of screening mammography: a meta-analysis.Science. 1995; 269: 1854-7.
, , , , , . Magnetic resonance elastography by direct visualization of propagating acoustic strain waves.Rockville, MD; 1999.
. Research Involoving Human Biological Materials: Ethical Issues and Policy Guidance. Volume I, Report and Recommendations of the National Bioethics Advisory Commission.J Natl Cancer Inst Monogr. 1997: 1-156. Proceedings. Bethesda, Maryland, USA.
. National Institutes of Health Consensus Conference on Breast Cancer Screening for Women Ages 40-49.Washington, D.C.: National Academy Press; 1999.
. The Small Business Innovation Research Program: Challenges and Opportunities.Hum Pathol. 1997; 28: 277-82.
, , , . Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction.[news]. J Natl Cancer Inst. 2000; 92: 592-4.
. Larger debate underlies spiral CT screening for lung cancerPage 262
J Clin Oncol. 1999; 17: 1259.
, , , et al. Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease.Acad Radiol. 1998 Sep; 5 Suppl 2: S310-3.
, . Digital mammography: a model for assessing cost-effectiveness.Br J Cancer. 1987; 56: 814-9.
, , , , . Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies.Radiology. 1997; 205: 399-406.
, , , et al. Digital tomosynthesis in breast imaging.Diagn Imaging (San Franc). 1999; 21: 47-51, 75.
. Computer-aided diagnosis complements full-field digital mammography.Proc Natl Acad Sci U S A. 2000; 97: 2767-72.
, , , . Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement.Proc Inst Mech Eng [H]. 1999; 213: 203-33.
, , , et al. Elastography: ultrasonic estimation and imaging of the elastic properties of tissues.Recent Results Cancer Res. 1998; 152: 35-48.
, , , , . Experimental pathology and breast cancer genetics: new technologies.Physiol Meas. 2000; 21: 99-109.
, , , , , . Multifrequency electrical impedance imaging: preliminary in vivo experience in breast.Proc Natl Acad Sci U S A. 1999; 96: 12589-94.
, , , et al. Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties.J Natl Cancer Inst. 1999; 91: 1113-24.
, , . Detection and clinical importance of micrometastatic disease.Cancer (Phila.). 1958; 11: 377-409.
, , , . Exfoliative cytology of the human mammary gland and its value in the diagnosis of cancer and other diseases of the breast.Am J Hum Genet. 1998; 62: 145-58.
, , . Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.Proc Natl Acad Sci U S A. 1999; 96: 9212-7.
, , , et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.Nature. 2000; 406: 747-52.
, , , et al. Molecular portraits of human breast tumours.JAMA. 1999; 282: 1869-72.
, . Medical innovation and the critical role of health technology assessment.Proc Natl Acad Sci U S A 1993 Mar 15; 90(6): 2556]. Proc Natl Acad Sci U S A. 1992; 89: 9064-8.
, , , . Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells [published erratum appears in2000. Lancet 355: 9217-1822.
, , , , . UK and USA Breast Cancer Deaths Down 25% in Year 2000 at Ages 20-69 Years [Letter];J Nucl Med. 2000; 41: 661-81.
. PET: the merging of biology and imaging into molecular imaging.Health Serv Res. 1998; 33: 29-53.
, , , , . Factors associated with women's adherence to mammography screening guidelines.Rockville, MD: Physicians Insurers Association of America; 1995.
. Breast Cancer Study.Page 263
Rockville, MD: Physicians Insurers Association of America; 1997.
. Practice Standards Claims Survey.Radiology. 1998a; 208: 245-9.
, , , , . Screening behavior of women after a false-positive mammogram.The RDOG5 investigators. Cancer. 1998b; 82: 679-88.
, , , et al. Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: The Radiologic Diagnostic Oncology Group 5 Study.Radiol Clin North Am. 2000; 38: 861-9, x.
, . Digital mammography, sestamibi breast scintigraphy, and positron emission tomography breast imaging.Acad Radiol. 2000; 7: 266-80.
, , , et al. Current status of full-field digital mammography.Eur. Radiology. 2000a; 10 Suppl. 3: 5430-2.
. A framework for evaluating the cost-effectiveness of MRI screening for breast cancer.Lucas Annual 2000. 2000b. Stanford, CA.
. Simulation of breast cancer screening trials. Outcomes and Cost-effectiveness (Methology Development).Phys Med Biol. 2000; 45: 1591-610.
, , , . Visualization and quantification of breast cancer biomechanical properties with magnetic resonance elastography.Nat Genet. 1999; 23: 41-6.
, , , et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays.Breast Cancer Res Treat. 1998; 47: 209-17.
. Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention.Med Care 1998 Oct; 36(10): 1470]. Med Care. 1998; 36: 257-70.
, , , . The association between health care coverage and the use of cancer screening tests. Results from the 1992 National Health Interview Survey [published erratum appears inPricewaterhouseCoopers Money Tree ™ Survey, www.pwcmoneytree.com (accessed August 2000 and March 2001).
Kramer BS, Gohagan JK, Prorok PC, eds. Cancer Screening: Theory and Practice. New York: M. Dekker; 1999: 29-53.
, , . Screening theory and study design: the basics. From:Cancer Epidemiol Biomarkers Prev. 1999; 8: 985-90.
, , , et al. Elevation of serum riboflavin carrier protein in breast cancer.3rd, , . Mandated coverage for cancer-screening services: whose guidelines do states follow? Am J Prev Med. 2000; 19: 71-8.
,Santa Monica, CA: RAND; 1997.
. Health Care in Transition: Technology Assessment in the Private Sector.J Natl Cancer Inst. 2000; 92: 184-6.
. Gene patent race speeds ahead amid controversy, concern.Bethesda, MD; 1999.
, , . SEER Cancer Statistic Review, 1973-1996.Radiology. 1989; 172: 243-6.
, , , , . Why women resist screening mammography: patient-related barriers.Am J Roentgenol. 1996; 167: 1415-9.
, , , et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology.Radiology. 1998; 209: 269-75.
, , , . Human breast lesions: characterization with proton MR spectroscopy.Pathol Annu. 1981; 16: 337-56.
. Clinical implications of preinvasive and small invasive breast carcinomas.Page 264
Cancer. 1980; 46: 919-25.
, , . The clinical significance of pre-invasive breast carcinoma.Anal Chem. 1975; 47: 592-602.
. Photoacoustic spectroscopy.Cancer. 1998; 82: 2235-40.
, . Screening mammography beginning at age 40 years: a reappraisal of cost-effectiveness.Science. 1997; 275: 1755-7.
, , , et al. Genetic information and the workplace: legislative approaches and policy changes.Am J Surg. 1997; 174: 694-6; discussion 697-8.
, , , et al. Use of fine needle aspiration for solid breast lesions is accurate and cost-effective.Environ Health Perspect. 1996; 104: 938-67.
, . Mammary gland neoplasia in long-term rodent studies.The Mammary Gland. 1987: 67-105. Plenum: New York.
, , Development of human mammary gland.ASAIO J. 2000; 46: 29-30.
. The conduct of clinical trials: a Food and Drug Agency perspective.Br J Cancer. 1999; 81: 1222-7.
, , , et al. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size.Br J Cancer. 1997; 76: 494-501.
, , , et al. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk.J Steroid Biochem Mol Biol. 1999; 71: 21-7.
, , , . Single nucleotide polymorphisms (SNPs) in the estrogen receptor gene and breast cancer susceptibility.Eur J Nucl Med. 1999; 26: 1279-88.
, , , , , . High-resolution scintimammography improves the accuracy of technetium-99m methoxyisobutylisonitrile scintimammography: use of a new dedicated gamma camera.Surg Clin North Am. 1999; 79: 991-1005.
, . Breast cancer. Making the diagnosis.Russia/St. Petersburg/WHO). Vopr Onkol. 1999; 45: 265-71.
, , , et al. Interim results of a prospective randomized study of self-examination for early detection of breast cancer ((results of the 5-years USSR/WHO randomized study in Leningrad). Eur J Epidemiol. 1992; 8: 498-502.
, , , et al. The role of breast self-examination in early breast cancer detectionScience. 2000; 289: 1673.
. Biochemistry. Protein arrays step out of DNA's shadow.Genes Chromosomes Cancer. 2000; 27: 124-9.
, , , et al. Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor.July 1997).
“Report of the Secretary to the President: Health insurance in the age of genetics.” (J Natl Cancer Inst Monogr. 1997: 27-30.
. Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan.Nature. 1997; 386: 804-10.
, , , et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2.Br J Cancer. 1998; 78: 922-7.
, , , et al. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients.Cancer Res. 1992; 52: 2984-6.
, , , et al. Inherited p53 gene mutations in breast cancer.JAMA. 1996; 276: 1339-41.
, , , . Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.Page 265
Oncology (Huntingt). 1997; 11: 393-406, 409-10; discussion 413-5.
, . Use of predictors of recurrence to plan therapy for DCIS of the breast.Phys Med Biol. 2000; 45: 1649-64.
, , , , , . High-resolution tensor MR elastography for breast tumour detection.Surg Clin North Am. 1999; 79: 961-90.
, . Breast cancer screening.Diagn Cytopathol. 1996; 14: 385-9.
, , , . Malpractice protection: communication of diagnostic uncertainty.Am J Med. 2000; 108: 112-9.
, , , . Is screening mammography effective in elderly women?1981; 41: 4637-43.
, , , , . Clonal proliferation of cultured nonmalignant and malignant human breast epithelia.Seminars in Breast Disease. 1999; 2: 280-91.
. Risk-Based Screening For Breast Cancer: Is There a Practical Strategy?1991; 1.
. A comparison of fine needle aspiration, core biopsy, and needle localization biopsy techniques in mammographically detectable nonpalpable breast lesions.2001.
. President Clinton signs bill to create NIH Institute of Biomedical Imaging and Bioengineering: NIH effort to build Office of Bioengineering, Bioimaging and Bioinformatics effectively derailed.Radiology. 1995; 196: 123-34.
, , , , , . Solid breast nodules: use of sonography to distinguish between benign and malignant lesions.[news]. Science. 2000; 287: 1575.
. Magnetic resonance imaging. Detecting enzyme activity in live animalsIssue Brief Natl Health Policy Forum. 1998: 1-8.
. Medicare coverage and technology diffusion: past, present, and future.N Engl J Med. 1997; 336: 1401-8.
, , , et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.Seminars In Breast Disease. 1999; 2: 97-106.
, , , , . Scintimammography.Radiology. 1999; 210: 345-51.
, , , , . Mammography in the 1990s: the United States and Canada.N Engl J Med. 1991; 325: 1831-6.
, , , . Incidence of cancer in 161 families affected by ataxia-telangiectasia.Surg Oncol Clin N Am. 2000; 9: 233-77.
, , , , . A new era in the diagnosis of breast cancer.Cancer. 1999; 86: 449-62.
, , , , . The natural history of breast carcinoma: what have we learned from screening?1999; 22: 414-8.
, , , , . Role of magnetic resonance imaging and magnetic resonance imaging—guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. Am J Clin Oncol.Nat Genet. 1996; 12: 333-7.
, , , et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.Freshney RI, Editor); Culture of Human Mammary Epithelial Cells. Culture of Epithelial Cells. Wiley-Liss, USA; 1992: 107-33.
, (1999; 1.
. Outlook For Medical Technology Innovation. Will Patients Get The Care They Need?2000; 2.
. Outlook For Medical Technology Innovation. Will Patients Get The Care They Need?J Natl Cancer Inst. 1997; 89: 355-65.
, , , et al. Randomized trial of breast self-examination in Shanghai: methodology and preliminary results.Page 266
Ann N Y Acad Sci 1998 Feb 9; 838: 171-93.
, . Physiological and pathological factors of human breast disease that can influence optical diagnosis.Radiology. 1994; 191: 241-4.
, , . Benefit of independent double reading in a population-based mammography screening program.Acta Radiol. 1998; 39: 384-8.
, , , . Sensitivity and specificity of computer-assisted breast cancer detection in mammography screening.J Steroid Biochem Mol Biol. 1997; 62: 119-28.
, . The role of estrogen receptor mutations in tamoxifen-stimulated breast cancer.OTA-H-608 ( Washington, D.C., U.S. Government Printing Office, September, 1994).
. “Identifying Health Technologies that Work: Searching for Evidence.”Department of Health and Human Services; 2000.
. Health, United States, 2000. With Adolescent Health Chartbook:1998a. GAO/HEHS98-164.
. Mammography Quality Standards Act: X-Ray Quality Improved, Access Unaffected, but Impact on Health Outcomes Unknown;1998b. GAO/HEHS-98-11.
. Mammography Services: Impact of Federal Legislation on Quality, Access, and Health Outcomes;Guide to Clinical Preventive Services. 2nd ed. Baltimore MD: Williams & Wilkins; 1996: 73-88. HealthSTAR.
, Screening for breast cancer. In:.Int J Cancer. 1996; 66: 727-31.
, , , et al. Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality.Cancer. 1993; 72: 1933-8.
, , , . The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers.Ann Surg. 1999; 229: 625-30; discussion 630-3.
, , , et al. Comparison of mammographically guided breast biopsy techniques.Soc Sci Med. 1990; 30: 1107-18.
, , . Participation in breast screening programs: a review.Arch Surg. 1996; 131: 967-72; discussion 972-4.
, , , , . Diagnosis of palpable breast lesions in younger women by the modified triple test is accurate and cost-effective.Diagn Imaging (San Franc). 1999; 21: 33-4, 62.
. Verdict on MQSA: quality up, but so is financial burden.Radiology 2000 Jul; 216(1): 306]. Radiology. 2000; 215: 554-62.
, , , et al. Potential contribution of computer-aided detection to the sensitivity of screening mammography [published erratum appears inDentomaxillofac Radiol. 1997; 26: 53-62.
, , , . Tuned-aperture computed tomography (TACT). Theory and application for three-dimensional dento-alveolar imaging.Curr Opin Obstet Gynecol. 1995; 7: 4-9.
. Prognostic factors in breast carcinoma.J Natl Cancer Inst. 1992; 84: 1875-87.
, , , et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.Ann Intern Med. 1997; 127: 1023-8.
, . Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find?Trends Genet. 2000; 16: 69-74.
, , . Insights into the functions of BRCA1 and BRCA2.Page 267
Cellular and Molecular Biology of Mammary Cancer. 1987: 163-79.
, , , , . Rodent models to examine in vivo hormonal regulation of mammary gland tumorigenesis.Ultrason Imaging. 1999; 21: 186-200.
. Volumetric Hall effect tomography—a feasibility study.IEEE Trans Biomed Eng. 1998; 45: 119-24.
, , . Hall effect imaging.J Natl Cancer Inst. 1998; 90: 906-10.
, , , et al. Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years.Public Health Paper (No. 34). Geneva, World Health Organization. 1968; 26.
, . Principles and practice of screening for disease.Kramer EJ, Ivey SL, Ying Y-W, Editors); Breast and Cervical Cancer. Immigrant Women's Health, Problems and Solutions. San Francisco, CA: Jossey-Bass Publishers; 1999.
(Adv Anat Pathol. 2000; 7: 26-35.
, , Recent developments in stereotactic breast biopsy methodologies: an update for the surgical pathologist.Nature 1996 Feb 22; 379(6567): 749]. Nature. 1995; 378: 789-92.
, , , et al. Identification of the breast cancer susceptibility gene BRCA2 [published erratum appears inAm J Epidemiol. 1992; 135: 130-41.
, , , et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid.Lifetime Data Anal. 1998; 4: 169-86.
, , . Estimating lifetime and age-conditional probabilities of developing cancer.Cancer Epidemiol Biomarkers Prev. 1999; 8: 749-57.
, . Interventions targeted toward patients to increase mammography use.Science. 2000; 289: 1890-2.
, , . Tech.sight. Genetic testing—present and future.Clin Cancer Res. 2000; 6: 1432-8.
, , , , , . CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer.Surg Oncol Clin N Am. 1999; 8: 17-33.
, , . The difficult breast.